SAN DIEGO, Jan. 27, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that Smartsheet Inc. (NYSE: SMAR) shareholders who held Smartsheet securities as of the record date, October 25, 2024, and were harmed by defendants' alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the acquisition of Smartsheet by Blackstone Inc., Vista Equity Partners Management, LLC, and the Abu Dhabi Investment Authority ("Merger"), have until February 24, 2026 to s ...

Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding delinquency rates in private education loans [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff in the class action lawsuit by February 17, 2026 [1]. - The lawsuit is titled Zappia v. SLM Corporation and is filed in the District of New Jersey [1]. - The allegations include that SLM experienced a significant increase in early-stage delinquencies, which was not disclosed to investors [3]. Group 2: Financial Impact - A report from TD Cowen on August 14, 2025, indicated that July 2025 delinquencies rose by 49 basis points month-over-month, which was worse than the seasonal average increase of 10 basis points [4]. - This report contradicted statements made by SLM's CFO, who claimed delinquency rates were following normal seasonal trends [4]. - Following the release of this report, SLM's stock price fell by approximately 8% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who invested in SLM securities during the class period to seek appointment as lead plaintiff [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [5]. - Participation as lead plaintiff does not affect an investor's ability to share in any potential recovery from the lawsuit [5]. Group 4: Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years [6]. - Robbins Geller has a significant history of obtaining large recoveries in securities class action cases, including the largest recovery of $7.2 billion in the Enron case [6].

NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of T1 Energy Inc. (“T1” or the “Company”) (NYSE: TE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether T1 and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On January 21, 2026, Culper Rese ...

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 24, 2026. So what: If you purchased Beyond Meat securities during the Class Period yo ...

New York, New York--(Newsfile Corp. - January 27, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Bath & Body Works, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/case ...

Core Viewpoint - A class action lawsuit has been filed against Integer Holdings Corporation and its senior executives for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Company Overview - Integer Holdings Corporation specializes in designing and manufacturing cardiac rhythm management and cardiovascular products, including electrophysiology devices that diagnose and treat arrhythmias [4]. Allegations of Securities Fraud - The lawsuit claims that Integer misrepresented the demand and revenue for its electrophysiology products, which had reportedly fallen sharply, contradicting the company's public statements about sales growth and market position [4][5]. Stock Price Decline - On October 23, 2025, Integer revised its 2025 sales guidance down to a range of $1.840 billion to $1.854 billion, significantly below analysts' expectations. The company also projected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. This announcement led to a stock price drop of $35.22 per share, or over 32%, from $109.11 to $73.89 [6].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit was filed by Bleichmar Fonti & Auld LLP and is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case, with claims asserted under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a 180-day cliff method for reserving accounts [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

BENSALEM, Pa., Jan. 27, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Smart Digital Group Limited ("SDM" or the "Company") (NASDAQ: SDM). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SMART DIGITAL GROUP LIMITED (SDM), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 16, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the ...

Group 1 - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sale of Penumbra, Inc. to Boston Scientific Corporation for $374.00 in cash or 3.8721 shares of Boston Scientific common stock [1] - RAPT Therapeutics, Inc. is being investigated for its sale to GSK plc for $58.00 per share [2] - The firm may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders, operating on a contingent fee basis [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC free of charge to discuss their legal rights and options [4] - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [4]

Group 1 - A class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. regarding potential securities fraud or unlawful business practices by the company and its officers [1][2] - Investors have until February 23, 2026, to request to be appointed as Lead Plaintiff if they purchased Quantum securities during the Class Period [2] - The lawsuit alleges that certain financial institutions engaged in manipulative trading practices, including spoofed sell orders, to create a false impression of Quantum's stock price decline [4] Group 2 - The defendants in the lawsuit include CIBC World Markets, RBC Dominion Securities, and Royal Bank of Canada, among others, who are accused of deceiving investors into selling shares at artificially low prices [4] - Pomerantz LLP, the law firm handling the case, is recognized for its expertise in corporate, securities, and antitrust class litigation, having a long history of fighting for victims of securities fraud [5]